Introduction to Nanomedicine, 7.5 credits

Academic year 2021/2022

  • Autumn 2021, 100%, Campus

    Start date: 1 December 2021

    End date: 16 January 2022

    Application deadline: 15 April 2021

    Application code: UU-39005 Application

    Language of instruction: English

    Location: Uppsala

    Selection: Higher education credits in science and engineering (maximum 240 credits)

  • Spring 2022, 100%, Campus

    Start date: 29 April 2022

    End date: 5 June 2022

    Application deadline: 15 October 2021

    Application code: UU-89005 Application

    Language of instruction: English

    Location: Uppsala

    Selection: Higher education credits in science and engineering (maximum 240 credits)

Entry requirements: For students from the:

Master of Sciences Programmes in Pharmacy and Chemical Engineering the student should have at least 150 credits in the programme, and passed the programme course(s) in physical chemistry and pharmaceutics.

Master Programme in Drug Discovery and Development the student should have passed the course in Molecular Biopharmaceutics.

For acceptance to freestanding course at least 150 credits are required including at least 15 credits in physical chemistry, pharmaceutics and pharmacokinetics.

Knowledge in English equivalent to what is required for basic eligibility to Swedish higher education.

Fees:

If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application or tuition fees. Formal exchange students will be exempted from tuition fees, as well as the application fee. Read more about fees.

Application fee: SEK 900

Tuition fee, first semester: SEK 18,125

Tuition fee, total: SEK 18,125

About the course

The course covers the principles in nanomedicine, especially with regard to the connection between physicochemical properties of nanomaterials, possible administration routes and their interactions with cells and tissues in the body. Further, it deals with the behavior of nanoparticles in biological fluids (e.g. plasma, intestinal fluid) and colloidal stability.

We study the basic principles for active (with ligands) and passive (e.g. for cancer therapy) targeting and uptake of nanoparticles in cells and tissues in the body. Furthermore, the course will cover nanoparticle and nanocarrier properties including the most important synthesis routes and characterisation methods. Special focus is also on diagnostic materials that can be used in imaging techniques or in theranostic formulations that combine disease diagnosis and therapy.

Finally, we will consider toxic, pharmacokinetic and regulatory aspects of nanomaterials in biomedical applications. For toxicity this includes a comparison of different external barriers that are exposed to nanomaterials, e.g. in the intestine, lungs, nose and skin.

More information

Contact

Department of Pharmacy

Biomedicinskt Centrum BMC, Husargatan 3 752 37 Uppsala

Box 580, 751 23 UPPSALA

Per Larsson

Email: per.larsson@farmaci.uu.se